• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Nuro hits communication milestone with non-surgical neurotech

Nuro hits communication milestone with non-surgical neurotech

May 2, 2025 By Sean Whooley

NURO LogoNuro recently announced a new clinical milestone with its third-generation neural operating system, NUOS 3.

The company reports that NUOS 3 can enable patients who have been declared clinically dead — at times for over 30 minutes — and later resuscitated to regain the ability to communicate. Despite complete entrapment and often suffering severe diffuse brain injuries, Nuro says its technology restores communication ability.

According to a news release, the individuals that can benefit from the technology were previously considered unreachable. However, they can now express intent and thoughts through the non-surgical NUOS 3 neurotechnology. This could aid patients in complex locked-instates caused by trauma, stroke, pharmatoxicology events, operative failures or deadly infections.

NUOS 3, a portable, wireless, lightweight system requires no surgery or implants. It can work at the bedside or in the home, delivering intuitive and immediate communication and control of computing. The system uses neurological signal analysis to enable communication.

According to Nuro, a woman in Boston with severe brain damage was able to use NUOS 3 to communicate with her family. The Canada-based company says its breakthrough paves the way for wider adoption in a range of locations. Those include emergency rooms, critical care units, palliative care units, rehabilitation centres and home settings.

“This is not science fiction. These are real patients, real families and real recoveries,” said Francois Gand, founder and CEO of Nuro. “NUOS 3 is enabling access to consciousness where even the most advanced medical systems believed there was none and the recommendation by clinicians was to end life support.”

Filed Under: Brain-Computer Interface (BCI), Clinical Trials, Health Technology, Neurological Tagged With: Nuro

More recent news

  • Medtronic nets CE mark for Vitalis family of conduction system pacemakers
  • E2’s pulmonary embolism platform claims two FDA clearances
  • Resmed to launch AirTouch F40 full-face fabric CPAP mask in US
  • Paradromics taps Siemens Healthineers to develop scalable BCI imaging
  • THL Partners’ new hire to target medtech, life sci tool developers

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy